Dr. Mohan'S Healthcare Products Profile
Key Indicators
- Authorised Capital ₹ 7.84 Cr
as on 09-07-2024
- Paid Up Capital ₹ 7.82 Cr
as on 09-07-2024
- Company Age 12 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -83.74%
(FY 2021)
- Profit 71.86%
(FY 2021)
- Ebitda 83.86%
(FY 2021)
- Net Worth -6.24%
(FY 2021)
- Total Assets -99.72%
(FY 2021)
About Dr. Mohan'S Healthcare Products
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.84 Cr and a paid-up capital of Rs 7.82 Cr, as per Ministry of Corporate Affairs (MCA) records.
Viswanathan Mohan, Ranjit Ittianath, and Ranjit Anjana serve as directors at the Company.
- CIN/LLPIN
U74900TN2012PTC084822
- Company No.
084822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2012
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dr. Mohan'S Healthcare Products?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viswanathan Mohan  | Director | 07-Mar-2012 | Current |
| Ranjit Ittianath | Director | 07-Mar-2012 | Current |
| Ranjit Anjana | Director | 07-Mar-2012 | Current |
Financial Performance and Corporate Structure Insights of Dr. Mohan'S Healthcare Products.
Dr. Mohan'S Healthcare Products Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 83.74% decrease. The company also saw a substantial improvement in profitability, with a 71.86% increase in profit. The company's net worth dipped by a decrease of 6.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dr. Mohan'S Healthcare Products?
In 2021, Dr. Mohan'S Healthcare Products had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr.Mohan's Diabetes Specialities Centre Private LimitedActive 34 years 2 monthsViswanathan Mohan, Ranjit Ittianath and 1 more are mutual person
Diabetes Supplies Centre LlpActive 7 years 10 monthsViswanathan Mohan, Ranjit Ittianath and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr. Mohan'S Healthcare Products?
Unlock and access historical data on people associated with Dr. Mohan'S Healthcare Products, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr. Mohan'S Healthcare Products, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr. Mohan'S Healthcare Products's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
